Compugen Ltd
CGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001119774
In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Compugen Ltd changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 66 | 65 | −1 |
| Shares | 12.3M | 12.0M | −318.3K (−2.6%) |
| Value | $20.7M | $21.7M | +$976.3K (+4.7%) |
New holders (4)
Institutions that held Compugen Ltd at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 47,675 | $86.3K | 0.00% |
| Hillsdale Investment Management Inc. | 38,480 | $69.6K | 0.01% |
| Two Sigma Advisers, LP | 18,484 | $33.5K | 0.00% |
| Tower Research Capital LLC (TRC) | 11,931 | $21.6K | 0.00% |
Sold out (5)
Institutions that held Compugen Ltd at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Qube Research & Technologies Ltd | 29,516 | $49.6K |
| Stephens Inc | 21,000 | $35.3K |
| Raymond James Financial Services Advisors, Inc. | 11,831 | $19.9K |
| Citigroup Inc | 1,610 | $2.71K |
| Simplex Trading, LLC | 603 | $1.00K |